Evidence-based medicine and equity: The exclusion of disadvantaged groups

Evidence-based Practice in Medicine and Health Care: A Discussion of the Ethical Issues

Volumn , Issue , 2005, Pages 129-138

  Rogers, Wendy A ^a  

^a FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 36549060826     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/3-540-27133-3_14     Document Type: Chapter

References (36)

1. Biller-Andorno N, Lie R, Ter-Meulen R (2002) Evidence based medicine as an instrument for rational health policy. Health Care Analysis 10: 261-275.
2. Bleyer W, Tejeda H, Murphy S, Brawley O, Smith M, Ungerleider R (1997) Equal participation of minority patients in U.S. national pediatric cancer clinical trials. Journal of Pediatric Hematology Oncology 19: 423-427.
3. Cookson R, McDaid D, Maynard A (2001) Wrong SIGN, NICE mess: is national guidance distorting allocation of resources? British Medical Journal 323: 743-5.
4. Dobson, F (1999) Secretary of State's speech, http://www.nice.org.uk/ Embcat.asp?page=oldsite/back/frank-dobson.htm&d=907.
5. Dresser R (1992) Wanted, Single white male. Hastings Center Report 22: 24-29.
6. Ebrahim S, Smith GD (1997) Systematic review of randomised controlled trials of multiple risk factor interventions for preventing coronary heart disease. British Medical Journal 314: 1666-1674.
7. Evelyn B, Toigo T, Banks D, Pohl D, Gray K, Robins B, Emat J (2001) Participation of racial/ethnic groups in clinical trials and race-related labelling: A review of new molecular entities approved 1995-1999. Journal of the National Medical Association 93: 18S-24S.
8. European Secondary Prevention Study Group (1996) Translation of clinical trials into practice: A European population-based study of the use of thrombolysis for acute myocardial infarction. Lancet 347: 1203-1207.
9. Giuliano A, Mokuau N, Hughes C, Tortolera-Luna G, Risendal B, Ho R, Prewitt T, McCaskill-Stevens W (2000) Participation of minorities in cancer research: The influence of structural, cultural and linguistic factors. Annals of Epidemiology 10: S22-S34.
10. Global Forum for Health Research (2002) The 10/90 report on health Research. Global Forum for Health Research, Geneva.
11. Horton R (2003) Medical journals: evidence of bias against the diseases of poverty. Lancet 361: 712-713.
12. Hanley B, Truesdale A, King A, Elbourne D, Chalmers I (2001) Involving consumers in designing, conducting, and interpreting randomised controlled trials: questionnaire survey. British Medical Journal 322: 519-523.
13. Heiat A, Gross C, Krumholz H (2002) Representation of the elderly, women, and minorities in heart failure clinical trials. Archives of Internal Medicine 162:1682-1688.
14. Hooper L, Summerbell C, Higgins J, Thompson R, Capps N, Smith GD, Ebrahim S (2001) Dietary fat intake and prevention of cardiovascular disease: A systematic review. British Medical Journal 322: 757-763.
15. Horrobin D (2003) Are large clinical trials in rapidly lethal diseases usually unethical? Lancet 361: 695-697.
16. Johnson J (2002) Influence of race or ethnicity on pharmacokinetics of drugs. Journal of Pharmaceutical Sciences 86: 1328-1333.
17. Kohl H (1995) Physical activity and cardiovascular disease: evidence for a dose response. Medicine and Science in Sports and Exercise 33: S472-S483.
18. Matthews H (1995) Racial, ethnic and gender differences in response to medicines. Drug Metabolism & Drug Interactions 12: 77-91.
19. McAlister F, Taylor L, Teo K, Tsuyuki R, Ackman M, Yim R, Montague T (1999) The treatment and prevention of coronary heart disease in Canada: do older patients receive efficacious therapies? Journal of the American Geriatrics Society 47: 811-818.
20. Miller B, Koloel L, Bernstein L, Young J, Swanson G, West D, et al. (1996) Racial/ethnic patterns of cancer in the United States 1988-92. Bethesda, MD: National Cancer Institute, Bethesda.
21. Giuliano A et al. (2000) Participation of minorities in cancer research: The influence of structural, cultural and linguistic factors. Annals of Epidemiology 10: S22-S34.
22. Moye LA, Powell JH (2001) Evaluation of ethnic minorities and gender effects in clinical trials: opportunities lost and rediscovered. Journal of the National Medical Association 93: 29S-34S.
23. Norheim OF (2002) The role of evidence in health policy making: A normative perspective. Health Care Analysis 10:309-317.
24. Owen W, Szczech L, Frankenfield D (2002) Health-care system interventions for inequality in quality: corrective action through Evidence-based Medicine. Journal of the National Medical Association 94: 83S-91S.
25. Raferty J (2001) NICE: faster access to modern treatments? Analysis of guidance on health technologies. British Medical Journal 323: 1300-1303.
26. Rochon P, Clark J, Binns M, Patel V, Gurwitz J (1998) Reporting of gender-related information in clinical trials of drug therapy for myocardial infarction. Canadian Medical Association Journal 159: 321-327.
27. Rogers WA (2002) Evidence-based Medicine in practice: Limiting or facilitating patient choice? Health Expectations 5: 95-103.
28. Sateren W, Trimble E, Brawley O, Breen N, Ford L, McCabe M, Ungerleider R, Christian M (2002) How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to can-cer treatment trials. Journal of Clinical Oncology 20: 2109-2117.
29. Sherr L (2000) Women and clinical trials. In: Sherr L, St Lawrence J (Eds.) Women, health and the mind. John Wiley and Sons, Chichester, P 47-58.
30. Starfield B (2001) New paradigms for quality in primary care. British Journal of General Practice 51: 303-309.
31. Sterne J, Egge M, Smith GD (2001) Investigating and dealing with publication and other biases in meta-analysis. British Medical Journal 323: 101-105.
32. Swanson GM, Bailar JC (2002) Selection and description of cancer clinical trials participants-science or happenstance? Cancer 95: 950-959.
33. Taylor AL (2001) SERMs, ethnicity, and clinical trials: opportunities and challenges. Annals of the New York Academy of Sciences 949: 292-294.
34. Watt G (2002) The inverse care law today. Lancet 360: 252-4.
35. Weissman N (2000) Relation of race and sex to the use of reperfusion therapy in Medicare beneficiaries with acute myocardial infarction. New England Journal of Medicine 324: 1094-1100.
36. World Health Organisation (2002) The World Health Report 2002. World Health Organisation, Geneva.